Medical Devices Series A Investors & VC Firms

1145 firms in this list, with a median first check of $500K. 237 of them lead rounds. Generated from verified public data and updated continuously.

Fund	FoxScore	HQ	Invests	Stage	Check	CRM
AV Aviv Venture Capital AGSCYZ3 people	88🔒	Tel Aviv	IL	Seed–Series A	—	+ Add to CRM
IN Inclusion Japan Leads rounds	88🔒	—	JP	Pre-Seed–Growth	—	+ Add to CRM
UN Unfold Ventures JSAJMSJS6 people	88🔒	Wrocław	PL	Pre-Seed–Late Stage	$110K – $1.1M	+ Add to CRM
WA Wallonie Entreprendre BLCFGLMB9 people	88🔒	Liège	BE	Pre-Seed–Late Stage	—	+ Add to CRM
AM Amzak Health JETNDSMC5 people	88🔒	New York	US	Seed–Late Stage	—	+ Add to CRM
TR Treo Ventures, Llc BHMJTPDS5 people	88🔒	Minneapolis	US	Seed–Late Stage	—	+ Add to CRM
RE Red Bike Capital HGRT2 people · Follows rounds	88🔒	New York	US	Pre-Seed–Series A	$25K – $1M	+ Add to CRM
VI VIVES Partners AVPDSSYV4 people	88🔒	Wavre	BE	Pre-Seed–Series B	$108K – $7.6M	+ Add to CRM
ME MEDA Ventures CCECTPJB9 people	88🔒	Arlington	US	Seed–Series A	—	+ Add to CRM
VI Virginia Venture Partners TWAEAFMR8 people	88🔒	Richmond	US	Pre-Seed–Series A	$100K	+ Add to CRM
DO DoubleRock NDSR2 people	88🔒	San Francisco	US	Seed–Series A	$2M – $15M	+ Add to CRM
RA Rapha Capital Management, LLC KS1 person	88🔒	Surfside	US	Seed–Series A	—	+ Add to CRM
AM Ambit Health Ventures NFMRSGZP4 people · Leads rounds	88🔒	Boston	US	Seed–Series B	—	+ Add to CRM
BL BlueStone Venture Partners MATNCBAM4 people	88🔒	Tucson	US	Seed–Series B	$250K – $1M	+ Add to CRM
AD AddVentures by SCG SPCLPJRM6 people	88🔒	Bangkok	TH	Seed–Late Stage	$1.5M – $66M	+ Add to CRM
BA Ballad Ventures MABWB3 people	88🔒	Johnson City	US	Pre-Seed–Series B	$500K – $1.5M	+ Add to CRM
CA Cancer Focus RPJPHAAG9 people	88🔒	Houston	US	Pre-Seed–Series A	—	+ Add to CRM
FU Funds Startups Leads rounds	88🔒	Tokyo	JP	Seed–Late Stage	$66M	+ Add to CRM
MA Mammoth Research EHJYKMMM9 people	88🔒	Fort Wayne	US	Series A–Growth	—	+ Add to CRM
RO Rockies Venture Adviser, Llc CSDHKKKM6 people · Leads rounds	88🔒	Denver	US	Pre-Seed–Series A	$100K – $500K	+ Add to CRM
AR Artiman Ventures ASASBWRR10 people	88🔒	Palo Alto	US	Seed–Late Stage	$2M – $6M	+ Add to CRM
AR Archetype Ventures HKJNKMSF6 people	88🔒	Tokyo	JP	Pre-Seed–Growth	$875K – $92M	+ Add to CRM
BR Brave Venture Capital LFŁFASAM9 people · Leads rounds	88🔒	Wrocław	PL	Pre-Seed–Series A	$540K	+ Add to CRM
IN InVivium Capital CCMLALAP6 people	88🔒	Chicago	US	Seed–Late Stage	—	+ Add to CRM

Aviv Venture Capital

Tel AvivSeed–Series A

AGSCYZ3 people

Inclusion Japan

Pre-Seed–Growth

Unfold Ventures

WrocławPre-Seed–Late Stage$110K – $1.1M

JSAJMSJS6 people

Wallonie Entreprendre

LiègePre-Seed–Late Stage

BLCFGLMB9 people

Amzak Health

New YorkSeed–Late Stage

JETNDSMC5 people

Treo Ventures, Llc

MinneapolisSeed–Late Stage

BHMJTPDS5 people

Red Bike Capital

New YorkPre-Seed–Series A$25K – $1M

HGRT2 people

VIVES Partners

WavrePre-Seed–Series B$108K – $7.6M

AVPDSSYV4 people

MEDA Ventures

ArlingtonSeed–Series A

CCECTPJB9 people

Virginia Venture Partners

RichmondPre-Seed–Series A$100K

TWAEAFMR8 people

DoubleRock

San FranciscoSeed–Series A$2M – $15M

NDSR2 people

Rapha Capital Management, LLC

SurfsideSeed–Series A

KS1 person

Ambit Health Ventures

BostonSeed–Series B

NFMRSGZP4 people

BlueStone Venture Partners

TucsonSeed–Series B$250K – $1M

MATNCBAM4 people

AddVentures by SCG

BangkokSeed–Late Stage$1.5M – $66M

SPCLPJRM6 people

Ballad Ventures

Johnson CityPre-Seed–Series B$500K – $1.5M

MABWB3 people

Cancer Focus

HoustonPre-Seed–Series A

RPJPHAAG9 people

Funds Startups

TokyoSeed–Late Stage$66M

Mammoth Research

Fort WayneSeries A–Growth

EHJYKMMM9 people

Rockies Venture Adviser, Llc

DenverPre-Seed–Series A$100K – $500K

CSDHKKKM6 people

Artiman Ventures

Palo AltoSeed–Late Stage$2M – $6M

ASASBWRR10 people

Archetype Ventures

TokyoPre-Seed–Growth$875K – $92M

HKJNKMSF6 people

Brave Venture Capital

WrocławPre-Seed–Series A$540K

LFŁFASAM9 people

InVivium Capital

ChicagoSeed–Late Stage

CCMLALAP6 people

Data sourced from public filings and firms' own websites — see our methodology.